EOLS

시간 외 거래: 7.97

Evolus Inc (EOLS)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Relative Volume:

Evolus Inc Stock (EOLS) Company Profile

Healthcare (1067)

(949) 284-4555

520 NEWPORT CENTER DRIVE, NEWPORT BEACH

@evolusaesthetic

최신 SEC 제출 서류

EOLS's Discussions on Twitter

Compare EOLS vs TAK, TEVA, HLN, ZTS, VTRS

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
EOLS Evolus Inc	7.97	526.42M	301.79M	-43.42M	-44.87M	-0.6705
TAK Takeda Pharmaceutical Co Adr	18.86	60.23B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	39.19	45.71B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.26	40.72B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	71.05	29.36B	9.51B	2.64B	2.14B	6.0361
VTRS Viatris Inc	17.83	20.48B	14.57B	-296.50M	1.64B	-0.259

Evolus Inc Stock (EOLS) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-08-06	다운그레이드	Needham	Buy → Hold
2025-04-17	개시	BTIG Research	Buy
2024-01-29	업그레이드	Barclays	Equal Weight → Overweight
2022-06-23	개시	Needham	Buy
2022-05-12	업그레이드	Barclays	Underweight → Equal Weight
2022-01-20	업그레이드	Truist	Hold → Buy
2021-05-06	업그레이드	Mizuho	Neutral → Buy
2021-04-08	재확인	H.C. Wainwright	Buy
2021-02-24	다운그레이드	Truist	Buy → Hold
2020-07-07	다운그레이드	Mizuho	Buy → Neutral
2020-02-06	재개	Mizuho	Buy
2019-11-26	개시	SVB Leerink	Outperform
2019-09-05	재개	Mizuho	Buy
2019-06-28	개시	Wells Fargo	Market Perform
2019-06-11	개시	Barclays	Underweight
2019-03-20	개시	SunTrust	Buy
2019-02-14	개시	H.C. Wainwright	Buy
2019-01-29	개시	Stifel	Buy

Evolus Inc 주식(EOLS)의 최신 뉴스

Evolus Inc (EOLS) 재무 분석

Evolus Inc (EOLS)

Evolus Inc Stock (EOLS) Company Profile

Compare EOLS vs TAK, TEVA, HLN, ZTS, VTRS

Evolus Inc Stock (EOLS) Upgrades & Downgrades

Evolus Inc 주식(EOLS)의 최신 뉴스

Evolus Deadline Alert - TMX Newsfile

Discover Evolus And Two Other Growth Companies With Strong Insider Backing - webull.com

Evolus, Inc. (EOLS) Stock Analysis: Exploring an 87% Potential Upside in the Aesthetic Beauty Market - DirectorsTalk Interviews

Evolus Q2 2026 Earnings: EPS Turns Positive at $0.02, Beating Estimates by 156.82%Dividend Earnings Report - dars.gov.et

(EOLS) Volatility Zones as Tactical Triggers - Stock Traders Daily

Evolus (EOLS) Notches A Profit Milestone While Betting Big On The Future - Yahoo Finance

Evolus Insider MOATAZEDI DAVID Sells 105,108 Shares at $9.04 Each (NASDAQ: EOLS) - Kalkine Media

Evolus president & CEO David Moatazedi sells $950,018 in shares By Investing.com - Investing.com UK

Evolus president & CEO David Moatazedi sells $950,018 in shares - Investing.com India

Evolus Officer Sold Shares Worth Over $950K - TradingView

Insider at Evolus (NASDAQ: EOLS) moves to sell nearly $1M in stock - Stock Titan

Evolus (EOLS) Advances 2.36% to $9.09, Holding Ground Above SupportRange Breakout - dars.gov.et

Evolus (EOLS) adds Soleus group as new 5.3% shareholder - Stock Titan

(EOLS) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Evolus, Inc. (EOLS) Reports Break-Even Earnings for Q2 - Eastern Progress

Wall Street Analysts Think Evolus (EOLS) Could Surge 77.68%: Read This Before Placing a Bet - Eastern Progress

Evolus (EOLS) Earnings Update: The EPS Result Is Above Expectation in the Current Update; Market Response: Shares Move Higher 2.22% on the DayEarnings Decline Risk - vinanet.vn

Evolus (EOLS) Results Check: EPS Prints Above Forecast in the Latest Reading; Trading Move - vinanet.vn

EOLS | Evolus, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative

Evolus (EOLS) Quarter in Focus: EPS Comes in Above Forecast on the Day; Share Move: The Share Price Adds 5.28% in the Current UpdateRevenue Warning Signal - vinanet.vn

Evolus (EOLS) Quarter in Focus: EPS Comes in Above Forecast on the Day; Share Move - dars.gov.et

Evolus (EOLS) Closing Note: Records a 5.28% Increase to $8.18 in the Latest Session; the Price Remains Bounded by the Supplied Support and Resistance in the Available RecordBearish Sentiment - vinanet.vn

EOLS Q2 2026 Earnings: EPS Turns Positive, Delivering 156.82% Surprise vs. EstimatesCost Structure Review - vinanet.vn

August 2026's Leading Growth Companies With Insider Confidence - Sahm

Midday Stock Roundup: Mobix Labs Shares Fall 21% at Midday - ocbj.com

Renaissance Technologies LLC Lowers Stake in Evolus, Inc. $EOLS - marketbeat.com

Evolus, Inc. (EOLS) Stock Price, News, Quote & History - Yahoo! Finance Canada

Assenagon Asset Management S.A. Grows Stock Holdings in Evolus, Inc. $EOLS - marketbeat.com

EOLS Q2 2026 Earnings: EPS Surprises to the Upside as Shares SlipSlow Growth Warning - careplusvn.com

Evolus (NASDAQ:EOLS) Reaches New 1-Year HighHere's What Happened - MarketBeat

Wall Street Analysts Believe Evolus (EOLS) Could Rally 106.08%: Here's is How to Trade - Yahoo Finance

Evolus: The Injectable Platform Is Becoming The Real Moat (NASDAQ:EOLS) - Seeking Alpha

EOLS Q2 2026 Earnings: EPS of $0.02 Beats Estimates by 156.8% as Profitability Inflection EmergesNew Analyst Coverage - dars.gov.et

Trading Systems Reacting to (EOLS) Volatility - Stock Traders Daily

Evolus (NASDAQ:EOLS) Rating Increased to Buy at Wall Street Zen - marketbeat.com

Needham Maintains Evolus(EOLS.US) With Hold Rating - moomoo.com

BTIG Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $13 - Moomoo

Evolus Inc (EOLS) Stock News Today - TradingKey

Evolus, Inc. (EOLS) Investor Outlook: Analyzing 97.93% Potential Upside in the Aesthetic Market - DirectorsTalk Interviews

Stifel Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $17 - Moomoo

Evolus Inc (EOLS) (Q2 2026) Earnings Call Highlights: Revenue Surges 21% and Adjusted EBITDA ... - Yahoo Finance

Evolus Inc (EOLS) (Q2 2026) Earnings Call Highlights: Revenue Su - GuruFocus

Earnings call transcript: Evolus tops revenue forecast in Q2 2026, shares rise - Investing.com UK

Evolus, Inc. Q2 2026 Financial Results: Revenue, Risks, and Key Business Updates - Minichart

Evolus Q2 Earnings Call Highlights - MarketBeat

Is Evolus Inc (EOLS) Undervalued After Q2 Earnings Beat? EPS: -0 - GuruFocus

Evolus Inc (EOLS) 재무 분석

매출

순이익

현금흐름

주당 순 이익

EOLS과 유사한 종목